Germany

Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, is pleased to announce that it has provided a financing package to support Avedon Capital Partners (“Avedon”) in the acquisition of FormMed HealthCare AG (“FormMed” or “the Company”). 

Maeander Capital with the support of Kartesia expands its shareholding in Soli Infratechnik alongside the existing shareholder and management to jointly pursue the future growth ambitions of the company.

Kartesia is pleased to announce that KSO I’s first investment, CC Group, which was completed on the first closing of the fund, has been exited already ahead of the its final close.

Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, has provided financing to Gilde Healthcare, a specialist healthcare investor, for its acquisition of Acti-Med, one of the leading manufacturers of medical technology, specialising in medical cannulas and cannula systems with production facilities in Germany and Poland. 

Kartesia is proud to announce the completion of its fifth investment from the Kartesia Senior Opportunities I fund (KSO I), with the financing of PlanetHome Group (“PlanetHome” or the “company”).

Kartesia, is proud to announce the completion of its first investment from Kartesia Senior Opportunities I (KSO I), the newly raised senior-lending fund, with the recapitalisation of CC Group, a portfolio company of Novum Capital, the Frankfurt-based independent investment firm. 

Kartesia is pleased to announce that the investment of the KCO III into the unitranche debt issued by Kufner was repaid at par following the exit of the Company by VMS.

KUFNER A few weeks ago KCO III arranged and purchased a €15M unitranche bond to finance the recapitalisation of Kufner Group, a German portfolio company of Austria-based private equity house Value Management Services (VMS). Kartesia’s Investment Manager Thomas Pöhler and Director Debt Advisory Daniel Gebler from DC Advisory tell us about the deal and current recapitalisation strategies.